
    
      Only subjects previously enrolled in studies CTAP101-CL-3001 or CTAP101-CL-3002 are eligible
      to participate in this extension study. This is a phase 3, open-label study of CTAP101
      Capsules, with and without add-on vitamin D hormone therapy.
    
  